Product
Moderna mRNA1273.222
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
DisCOVEries 2 - An Observational Study to Evaluate the Immunogenicity of mRNA COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)Status: Active (not recruiting), Estimated PCD: 2024-06-30